Circulating Inflammation Markers and Pancreatic Cancer Risk: A Prospective Case-Cohort Study in Japan
Enbo Ma(Fukushima Medical University), Shoichiro Tsugane(International University of Health and Welfare), M. Constanza Camargo(National Institutes of Health), Ruth M. Pfeiffer(National Institutes of Health), Taiki Yamaji, Lígia A. Pinto(Leidos (United States)), Troy J. Kemp(Leidos (United States)), Minkyo Song(National Institutes of Health), Norie Sawada(National Cancer Center), Manami Inoue(Fukuoka University), Taichi Shimazu, Hadrien Charvat(Juntendo University), Charles S. Rabkin(National Cancer Institute)
Cited by 4
Related Papers
Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
|Nature Medicine|2019|1.5k
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
|Nature Genetics|2013|922
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
|Cancer Cell|2018|718
Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study
|The Lancet Oncology|2021|684
What has made the population of Japan healthy?
|The Lancet|2011|677